Novo Nordisk is looking at a site in Dublin for a new factory to ease global supply shortages of its weight-loss “wonder drug” Wegovy.
Land has been acquired at Grange Castle Business Park in Clondalkin for a 1.6m sq ft facility to make drugs for diabetes, obesity and rare diseases. A ruling on Novo’s planning application is due before the end of the month.
The Danish group’s choice of the Republic of Ireland as a potential location for an estimated €2bn investment has turned the spotlight on the country’s appeal over Britain as a place to manufacture medicines.
